← Open Payments lookup

FERNANDO SERRANO: Open Payments

NPI 1083247779 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,058 in 102 payments from 9 companies in 2025. Trend: 2023 $2,337 · 2024 $3,410 · 2025 $3,058

Food & beverage: $3,048Education: $10
CompanyPaymentsAmount
Alkermes, Inc.21$697
Neurocrine BioSciences, Inc.11$459
E.R. Squibb & Sons, L.L.C.11$351
Otsuka America Pharmaceutical, Inc.13$330
Teva Pharmaceuticals USA, Inc.13$314
Janssen Pharmaceuticals, Inc9$311
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$249
Vanda Pharmaceuticals Inc.9$234
Lundbeck LLC5$113

Products named: INGREZZA, ARISTADA, REXULTI, COBENFY, LYBALVI, INVEGA SUSTENNA, CAPLYTA, FANAPT.

Industry payments across CA — which companies pay providers there.